Myriad Genetic Laboratories, Inc., focuses on developing and marketing new predictive and personalized medicine products, using innovative technology to perform the highest quality testing available.
The era of individualized medicine is upon us, one in which patients are evaluated to receive more targeted therapy. Healthcare professionals want more individualized information and knowledge about their patients to improve treatment outcomes. Already a world leader in offering a range of hereditary cancer and other predictive medicine products, we are currently developing products to help oncologists optimize their patients' chemotherapy.
OnDose™ is the first of these products. OnDose is a simple blood test that provides the data for pharmacokinetically-guided dose adjustments of infusional 5-FU to help optimize dosing for patients with colorectal cancer.
We encourage you to explore our Web site to learn about the first of our chemotherapy dose optimization products: OnDose.
Myriad Certifications
Myriad Genetic Laboratories, Inc., has the following clinical laboratory certifications. Please note that you need the free Adobe Acrobat Reader software to view PDF files.
Myriad Genetic Laboratories, Inc.
320 Wakara Way, Salt Lake City, UT 84108
1-800-469-7423 | E-mail: ondose@myriad.com
Myriad, the Myriad logo, and OnDose are either trademarks or registered trademarks of Myriad Genetics, Inc., in the United States and other jurisdictions.
